(Q38266303)

1 September 2017

0 references

1 reference

title

Review: efficacy and safety of hybrid therapy for Helicobacter pylori infection: a systematic review and meta-analysis (English)

1 reference

Helicobacter pylori infectious disease

1 September 2017

0 references

1 reference

1 reference

1 reference

Ben Wang

1

1 reference

1 September 2017

You-Hua Wang

2

1 reference

1 September 2017

Zhi-Fa Lv

3

1 reference

1 September 2017

Hui-Fang Xiong

4

1 reference

1 September 2017

Hui Wang

5

1 reference

1 September 2017

Yang Yang

6

1 reference

1 September 2017

Yong Xie

7

1 reference

1 September 2017

8 November 2014

1 reference

1 September 2017

1 reference

1 September 2017

20

1 reference

1 September 2017

2

1 reference

1 September 2017

79-88

1 reference

Clinical practice. Helicobacter pylori infection

1 September 2017

1 reference

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

Helicobacter pylori treatment in the era of increasing antibiotic resistance

21 January 2018

1 reference

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

21 January 2018

1 reference

Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence

21 January 2018

1 reference

Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis

21 January 2018

1 reference

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

21 January 2018

1 reference

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.

21 January 2018

1 reference

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days

21 January 2018

1 reference

Treatment of Helicobacter pylori infection 2013.

21 January 2018

1 reference

Comparison of the efficacy of the two tetracycline-containing sequential therapy regimens for the eradication of Helicobacter pylori: 5 days versus 14 days amoxicillin

21 January 2018

1 reference

Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate.

21 January 2018

1 reference

Helicobacter pylori: tailored therapy with novel sequential quadruple therapies

21 January 2018

1 reference

Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial.

21 January 2018

1 reference

Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance

21 January 2018

1 reference

Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study

21 January 2018

1 reference

[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference].

21 January 2018

1 reference

"Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy.

21 January 2018

1 reference

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection

21 January 2018

1 reference

Antibiotic resistance in Helicobacter pylori: implications for therapy.

21 January 2018

1 reference

H pylori antibiotic resistance: prevalence, importance, and advances in testing

21 January 2018

1 reference

Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China

21 January 2018

1 reference

Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.

21 January 2018

1 reference

Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?

21 January 2018

1 reference

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

21 January 2018

1 reference

Clarithromycin-resistant genotypes and eradication of Helicobacter pylori.

21 January 2018

1 reference

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection

21 January 2018

1 reference

Current options for the treatment of Helicobacter pylori

21 January 2018

1 reference

Understanding and appreciating sequential therapy for Helicobacter pylori eradication

21 January 2018

1 reference

A new look at anti-Helicobacter pylori therapy

21 January 2018

1 reference

Sequential metronidazole-furazolidone or clarithromycin-furazolidone compared to clarithromycin-based quadruple regimens for the eradication of Helicobacter pylori in peptic ulcer disease: a double-blind randomized controlled trial

21 January 2018

1 reference

Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy.

21 January 2018

1 reference

Attempts to enhance the eradication rate of Helicobacter pylori infection

21 January 2018

1 reference

Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy

21 January 2018

1 reference

Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study

21 January 2018

1 reference

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HEL.12180

1 reference

1 September 2017

1 reference